INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 124 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,964,000 | +63.0% | 398,345 | +36.6% | 0.08% | +48.1% |
| Q4 2017 | $1,205,000 | +27.2% | 291,713 | +95.3% | 0.05% | +5.9% |
| Q3 2017 | $947,000 | -16.6% | 149,385 | +3.1% | 0.05% | -45.7% |
| Q2 2017 | $1,136,000 | +34.8% | 144,859 | +13.7% | 0.09% | +11.9% |
| Q1 2017 | $843,000 | +14.4% | 127,375 | +20.0% | 0.08% | -5.6% |
| Q4 2016 | $737,000 | +24.7% | 106,147 | +67.5% | 0.09% | +12.7% |
| Q3 2016 | $591,000 | +0.9% | 63,383 | 0.0% | 0.08% | -3.7% |
| Q2 2016 | $586,000 | -68.1% | 63,383 | -70.0% | 0.08% | -27.4% |
| Q1 2016 | $1,838,000 | +143.1% | 210,984 | +87.5% | 0.11% | +17.7% |
| Q4 2015 | $756,000 | – | 112,524 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |